Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Amgen and Daiichi Sankyo Company announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal includes several biosimilars in...
AstraZeneca receives approval in the EU for Qtern for treatment of Type 2 diabetes
AstraZeneca announced that the EC has approved Qtern tablets for the treatment of type 2 diabetes in all 28 EU member countries plus Iceland,...
Abbott laboratories says U.S. FDA approves tecnis symfony intraocular lenses
- Approval includes toric version of symfony iol for people with astigmatism- lenses provide high-quality continuous vision so patients can see clearly at near,...
Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines
• Collaboration aims to develop PROteolysis TArgeting Chimeric molecules (PROTACs) – a new therapeutic modality that is able to degrade proteins playing a central...
Health Canada approves Abbott’s Absorb Bioresorbable Stent
Abbott announced that Health Canada has approved the company's Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people in...
Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines
Bayer and X-Chem, Inc focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, have entered into an...
AbbVie Receives U.S. FDA Rare Pediatric Disease Designation for Investigational ABT
AbbVie a global biopharmaceutical company, announced that the U.S. FDA granted Rare Pediatric Disease Designation for ABT-414, an investigational antibody drug conjugate (ADC) targeting...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...